#16: TheMachine: Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
SEATTLE, Sept. 17 /PRNewswire-FirstCall/ --... |
September 20, 2008
01:13:47 AM |
#15: NewsBot: Dendreon Announces Closing of Registered Direct Offering
Dendreon Announces Closing of Registered Direct Offering
... |
April 13, 2008
03:47:45 PM |
#14: TheMachine: FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
-Amended Agreement Accelerates Expected Timing of Final... |
March 13, 2008
05:19:25 AM |
#13: TheMachine: Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
SEATTLE, March 3 /PRNewswire-FirstCall/--... |
March 13, 2008
05:19:03 AM |
#12: FastFun: Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints and Dendreon Soars on Provenge Probe Request
--(www.USEquityNews.com)-- 12/14/2007 - Pharmaceutical industry alert... |
December 14, 2007
02:12:44 PM |
#11: FastFun: Amgen Discussing Aranesp Label Changes and Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
--(www.USEquityNews.com)-- 12/10/2007 - Pharmaceutical industry alert... |
December 10, 2007
10:03:17 PM |
#10: FastFun: Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
SEATTLE, Dec. 7 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq:... |
December 7, 2007
07:21:59 PM |
#9: FastFun: Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
--FDA Has Agreed That Positive Survival Data from IMPACT Study Would... |
November 26, 2007
09:22:18 PM |
#8: FastFun: Dendreon Secures $130 Million Committed Equity Financing Facility
SEATTLE, Oct. 12 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq:... |
November 26, 2007
09:20:40 PM |
#7: JosBlog: prostate cancer drug
I don't understand why the FDA will not allow the use of the drug Provenge to... |
June 4, 2007
06:10:56 PM |
#6: Jason: Provenge Discussed on abcNews
Protestors march on the grounds of the FDA. Is the FDA correct for blocking... |
June 4, 2007
05:54:05 PM |
#5: Jason: DNDN, Dendreon Corporation Announces Proposed $75 Million Convertible Senior Subordinated Notes Offering
Dendreon Corporation (Nasdaq: DNDN Stock Forum) today announced the Company... |
June 4, 2007
08:35:28 AM |
#4: Jason: DNDN share holders sigh of relief
DNDN started up today in AH. The FDA has given the green light to... |
May 31, 2007
02:51:43 PM |
#3: Jason: DNDN Up in AH
DNDN share holders are getting some welcomed relief as share are up .86 in AH. |
May 31, 2007
08:18:53 AM |
#2: Jason: I am glad to see the stock up today
Will we see sustained run again? |
May 29, 2007
09:54:06 AM |
| 
| 
| 
| 
| 
| 
